Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Readies for the Next Phase of Growth with the Appointment of Neha Krishnamohan as CFO and EVP, Corporate Development and Promotion of Jennifer Bush to Chief Operating Officer
Read Article
News
2024
2023
Archive
Search news articles
April 4, 2016
FLEXION THERAPEUTICS ANNOUNCES PRESENTATION OF RESULTS FROM PIVOTAL PHASE 2B AND PHASE 3 CLINICAL TRIALS FOR ZILRETTA™ AT OSTEOARTHRITIS RESEARCH SOCIETY INTERNATIONAL (OARSI) 2016 WORLD CONGRESS
March 9, 2016
CANCER COMPANY APREA CLOSES EUR 46 MILLION (~USD 51 MILLION) SERIES B FINANCING
February 3, 2016
PEAR THERAPEUTICS CLOSES $20 MILLION FINANCING
February 3, 2016
VENTUREWIRE: PEAR THERAPEUTICS RAISES $20M FOR DIGITAL SUBSTANCE-ABUSE TREATMENT
January 11, 2016
ACHAOGEN ANNOUNCES ENROLLMENT OF FIRST PATIENT IN EPIC, A PHASE 3 CLINICAL TRIAL FOR THE TREATMENT OF COMPLICATED URINARY TRACT INFECTIONS (CUTI) WITH PLAZOMICIN
January 5, 2016
MILLENDO LICENSES PHASE 2 POLYCYSTIC OVARY SYNDROME (PCOS) DRUG CANDIDATE FROM ASTRAZENECA AND SECURES SERIES B FINANCING OF $62 MILLION TO ADVANCE PIPELINE OF ENDOCRINE DISORDER THERAPIES
December 17, 2015
5AM VENTURES ANNOUNCES PROMOTIONS AND TEAM EXPANSION
December 4, 2015
JOHNSON & JOHNSON ANNOUNCES COMPLETION OF NOVIRA THERAPEUTICS, INC. ACQUISITION
November 4, 2015
NOVIRA THERAPEUTICS ANNOUNCES ACQUISITION AGREEMENT WITH JOHNSON & JOHNSON
November 4, 2015
SCPHARMACEUTICALS ANNOUNCES POSITIVE RESULTS FROM PIVOTAL TRIAL OF ITS NOVEL SUBCUTANEOUS FUROSEMIDE FORMULATION IN PATIENTS WITH HEART FAILURE
« Previous Page
1
…
94
95
96
97
98
…
119
Next Page »